Incidental Mutation 'R8297:Ltb'
ID 639043
Institutional Source Beutler Lab
Gene Symbol Ltb
Ensembl Gene ENSMUSG00000024399
Gene Name lymphotoxin B
Synonyms p33, Tnfc, lymphotoxin beta, LTbeta, Tnfsf3
MMRRC Submission 067853-MU
Accession Numbers
Essential gene? Probably non essential (E-score: 0.097) question?
Stock # R8297 (G1)
Quality Score 225.009
Status Validated
Chromosome 17
Chromosomal Location 35413483-35415281 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) G to T at 35413655 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Arginine to Leucine at position 53 (R53L)
Ref Sequence ENSEMBL: ENSMUSP00000025262 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000025262] [ENSMUST00000025263] [ENSMUST00000167924] [ENSMUST00000173600]
AlphaFold P41155
Predicted Effect probably benign
Transcript: ENSMUST00000025262
AA Change: R53L

PolyPhen 2 Score 0.002 (Sensitivity: 0.99; Specificity: 0.30)
SMART Domains Protein: ENSMUSP00000025262
Gene: ENSMUSG00000024399
AA Change: R53L

DomainStartEndE-ValueType
transmembrane domain 21 43 N/A INTRINSIC
low complexity region 72 85 N/A INTRINSIC
TNF 154 305 8.76e-42 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000025263
SMART Domains Protein: ENSMUSP00000025263
Gene: ENSMUSG00000024401

DomainStartEndE-ValueType
transmembrane domain 35 57 N/A INTRINSIC
TNF 91 235 1.59e-53 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000167924
SMART Domains Protein: ENSMUSP00000126122
Gene: ENSMUSG00000024401

DomainStartEndE-ValueType
transmembrane domain 35 57 N/A INTRINSIC
TNF 74 219 2.8e-49 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000173600
SMART Domains Protein: ENSMUSP00000134706
Gene: ENSMUSG00000024399

DomainStartEndE-ValueType
TNF 33 184 8.76e-42 SMART
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 100.0%
  • 10x: 99.7%
  • 20x: 99.1%
Validation Efficiency 100% (61/61)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Lymphotoxin beta is a type II membrane protein of the TNF family. It anchors lymphotoxin-alpha to the cell surface through heterotrimer formation. The predominant form on the lymphocyte surface is the lymphotoxin-alpha 1/beta 2 complex (e.g. 1 molecule alpha/2 molecules beta) and this complex is the primary ligand for the lymphotoxin-beta receptor. The minor complex is lymphotoxin-alpha 2/beta 1. LTB is an inducer of the inflammatory response system and involved in normal development of lymphoid tissue. Lymphotoxin-beta isoform b is unable to complex with lymphotoxin-alpha suggesting a function for lymphotoxin-beta which is independent of lympyhotoxin-alpha. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for targeted null mutations lack peripheral lymph nodes, Peyer's patches, splenic germinal centers and follicular dendritic cells. Mutants exhibit lymphocytosis in the circulation and peritoneal cavity with infiltrations of the lung and liver. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 62 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
1700020N01Rik T C 10: 21,497,578 (GRCm39) L73P probably damaging Het
4933412E24Rik T G 15: 59,887,524 (GRCm39) R305S probably damaging Het
Adamts19 T A 18: 58,970,920 (GRCm39) V168E probably damaging Het
Ankrd34b T A 13: 92,576,097 (GRCm39) L443Q probably damaging Het
Ano3 A G 2: 110,491,616 (GRCm39) Y887H probably damaging Het
Arhgef2 A T 3: 88,546,739 (GRCm39) H553L probably benign Het
Atxn1 G T 13: 45,720,505 (GRCm39) N463K probably benign Het
Birc6 A G 17: 74,932,099 (GRCm39) probably null Het
C4bp A G 1: 130,564,482 (GRCm39) S401P probably damaging Het
Cd5 T A 19: 10,697,609 (GRCm39) R457W probably damaging Het
Chek2 T G 5: 110,996,302 (GRCm39) Y127D probably damaging Het
Clec4a1 G A 6: 122,898,960 (GRCm39) V10M probably damaging Het
Cltc A G 11: 86,603,457 (GRCm39) Y790H probably damaging Het
Cops2 T C 2: 125,701,028 (GRCm39) probably benign Het
Cyb5d2 A G 11: 72,679,929 (GRCm39) F122S probably damaging Het
Daam1 T A 12: 71,998,689 (GRCm39) L548H unknown Het
Dcp1a A G 14: 30,244,883 (GRCm39) T570A possibly damaging Het
Dsg1a A C 18: 20,465,090 (GRCm39) N427T probably benign Het
Ear14 A T 14: 51,441,564 (GRCm39) D140V probably damaging Het
Epha4 A C 1: 77,483,547 (GRCm39) F154C probably damaging Het
Ets2 G A 16: 95,507,321 (GRCm39) V12M probably damaging Het
Fbxo40 G A 16: 36,789,670 (GRCm39) T480I probably damaging Het
Fdps A T 3: 89,001,048 (GRCm39) Y322N probably damaging Het
Gca T C 2: 62,516,700 (GRCm39) M132T probably benign Het
Ifi203 T G 1: 173,765,496 (GRCm39) K26T probably damaging Het
Itga10 A G 3: 96,562,116 (GRCm39) R668G probably damaging Het
Itgal T C 7: 126,929,638 (GRCm39) I1185T unknown Het
Kcnj13 A T 1: 87,314,189 (GRCm39) N344K probably damaging Het
Kdm5a A T 6: 120,358,516 (GRCm39) L186F probably benign Het
Klhl8 T C 5: 104,010,954 (GRCm39) N624D probably benign Het
Klrb1 G T 6: 128,689,222 (GRCm39) T83K possibly damaging Het
Krt77 TGCCGCCGCCGCCGCCGCCGCCGCCGC TGCCGCCGCCGCCGCCGCCGCCGC 15: 101,768,407 (GRCm39) probably benign Het
Mterf3 A G 13: 67,055,222 (GRCm39) V69A Het
Mvb12a A G 8: 71,997,888 (GRCm39) K101E probably damaging Het
Nbeal2 T A 9: 110,464,409 (GRCm39) Q1110L possibly damaging Het
Neb T A 2: 52,198,775 (GRCm39) T389S possibly damaging Het
Nol4 A G 18: 23,173,069 (GRCm39) F11L probably damaging Het
Or10p22 T C 10: 128,826,708 (GRCm39) L309P possibly damaging Het
Or2a54 A G 6: 43,093,440 (GRCm39) I255V probably benign Het
Or2h15 A G 17: 38,441,484 (GRCm39) S200P probably damaging Het
Or52e8b C T 7: 104,673,885 (GRCm39) G97R probably benign Het
Pde2a T A 7: 101,153,880 (GRCm39) Y487N possibly damaging Het
Pde4a C T 9: 21,077,404 (GRCm39) P61S possibly damaging Het
Pramel16 T A 4: 143,675,690 (GRCm39) T379S probably benign Het
Prr5l A G 2: 101,571,630 (GRCm39) probably null Het
Ptpn6 G A 6: 124,705,614 (GRCm39) T179I possibly damaging Het
Ralyl T C 3: 14,104,836 (GRCm39) S34P probably benign Het
Rftn1 G T 17: 50,354,408 (GRCm39) A318D probably damaging Het
Robo2 A T 16: 73,812,814 (GRCm39) C293* probably null Het
Rtn4 T G 11: 29,655,536 (GRCm39) D169E probably damaging Het
Slc22a22 A T 15: 57,122,506 (GRCm39) V157E probably damaging Het
Sytl2 A G 7: 90,034,283 (GRCm39) T498A probably benign Het
Tgm6 G A 2: 129,979,358 (GRCm39) V163I probably benign Het
Tnpo3 A T 6: 29,582,302 (GRCm39) C187S possibly damaging Het
Ttn A G 2: 76,616,485 (GRCm39) probably null Het
Tut4 G A 4: 108,336,905 (GRCm39) A210T possibly damaging Het
Vangl2 C A 1: 171,837,513 (GRCm39) V99F possibly damaging Het
Vmn1r167 C T 7: 23,204,215 (GRCm39) C267Y probably damaging Het
Vsig10l T C 7: 43,113,531 (GRCm39) V161A possibly damaging Het
Xrcc5 G A 1: 72,364,244 (GRCm39) R232Q possibly damaging Het
Xrcc6 C G 15: 81,913,463 (GRCm39) F365L probably damaging Het
Zdhhc13 A G 7: 48,465,257 (GRCm39) Y389C probably damaging Het
Other mutations in Ltb
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00944:Ltb APN 17 35,413,642 (GRCm39) missense possibly damaging 0.78
IGL01112:Ltb APN 17 35,413,576 (GRCm39) missense probably benign 0.04
IGL02263:Ltb APN 17 35,414,977 (GRCm39) missense probably damaging 1.00
IGL02983:Ltb APN 17 35,413,646 (GRCm39) missense probably benign 0.15
IGL02995:Ltb APN 17 35,414,348 (GRCm39) splice site probably benign
IGL03389:Ltb APN 17 35,414,044 (GRCm39) missense probably benign 0.00
R0103:Ltb UTSW 17 35,414,016 (GRCm39) intron probably benign
R0103:Ltb UTSW 17 35,414,016 (GRCm39) intron probably benign
R2060:Ltb UTSW 17 35,414,739 (GRCm39) missense probably damaging 0.97
R4718:Ltb UTSW 17 35,414,313 (GRCm39) splice site probably null
R4823:Ltb UTSW 17 35,414,206 (GRCm39) missense probably benign
R4884:Ltb UTSW 17 35,414,234 (GRCm39) missense probably benign
R5231:Ltb UTSW 17 35,414,802 (GRCm39) missense probably damaging 1.00
R5327:Ltb UTSW 17 35,414,935 (GRCm39) missense probably damaging 1.00
R8344:Ltb UTSW 17 35,414,169 (GRCm39) missense probably benign 0.41
R9778:Ltb UTSW 17 35,414,906 (GRCm39) nonsense probably null
Predicted Primers PCR Primer
(F):5'- CTGAGGTATGAAAGCCCCTG -3'
(R):5'- TGCAGTGTTATCTGGAAAAGAAGC -3'

Sequencing Primer
(F):5'- CCCCGGTCCTAGTTCTGAG -3'
(R):5'- TGTTATCTGGAAAAGAAGCCAACC -3'
Posted On 2020-07-28